Imugene Ownership

Imugene has a total of 7.57 Billion outstanding shares. Imugene retains 14.38 (percent) of its outstanding shares held by insiders and 6.6 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Imugene in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Imugene, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Dividends Paid is likely to gain to about 94.1 M in 2024. Common Stock Shares Outstanding is likely to gain to about 7.4 B in 2024, despite the fact that Net Loss is likely to grow to (32.4 M). Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imugene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.